Clinical trial • Not applicable • Endocrinology|Psychiatry

Clinical trial in Gender dysphoria|Transsexualism

Not applicable trial for Gender dysphoria|Transsexualism. 70 participants.

Overview

Trial Therapeutic Area
Endocrinology|Psychiatry
Trial Disease
Gender dysphoria|Transsexualism
Trial Stage
Not applicable

Key dates

Initial CTIS Submission Date
04-09-2024
First CTIS Authorization Date
01-10-2024

Trial design

Not applicable trial in Sweden.

Target Sample Size
70

Eligibility

Recruits 70 No vulnerable population selected (isVulnerablePopulationSelected=false); no consent/assent details available..

Vulnerable Population
No vulnerable population selected (isVulnerablePopulationSelected=false); no consent/assent details available.

Recruitment

Planned Sample Size
70
Recruitment Window Months
36

Geography

Total Number Of Sites
1
Total Number Of Participants
70

Sweden

Earliest CTIS Part Ii Submission Date
23-09-2024
Latest Decision Or Authorization Date
01-10-2024
Processing Time Days
8
Number Of Sites
1
Number Of Participants
70

Sites

Site Name
Karolinska University Hospital
Department Name
ME Endokrinologi
Principal Investigator Name
Mats Holmberg
Principal Investigator Email
mats.holmberg.1@ki.se
Contact Person Name
Mats Holmberg
Contact Person Email
mats.holmberg.1@ki.se

Sponsor

Primary sponsor

Full Name
Karolinska University Hospital
Organisation Type
Hospital/Clinic/Other health care facility
Country Of Registered Address
Sweden

Related trials

Other published trials that may interest you.